Ready to build idle vaccine capacities via long-term contracts: Poonawalla

Aim is to reach region that do not have capacities to manufacture vaccines and give them priority and fixed price

Serum Institute has offered to create large-scale empty vaccine manufacturing capacities to some regions which do not have substantial vaccine manufacturing capacities as preparedness for future pandemics, CEO Adar Poonawalla said.

Poonawalla, the CEO of the world’s largest vaccine manufacturer by volumes, was speaking at the Indian Global Forum.

He explained that this would mean entering into long-term contracts with a country or region which does not have capacities to manufacture vaccines; giving them the priority and at a fixed price. “Imagine that you could have a 15-year idle capacity for a small reservation fee to a manufacturer who can